Skip to main content
رجوع
Watch Compare

AYTU BIOPHARMA, INC

جودة البيانات: 100%
AYTU
Nasdaq Manufacturing Chemicals
KWD 2.57
▼ KWD 0.09 (-3.38%)
القيمة السوقية: 27.58 M
السعر
KWD 2.57
القيمة السوقية
27.58 M
نطاق اليوم
KWD 2.57 — KWD 2.68
نطاق 52 أسبوعًا
KWD 0.98 — KWD 3.07
حجم التداول
26,737
فتح KWD 2.61
متوسط 50 يوم / 200 يوم
KWD 2.52
2.01% above
متوسط 50 يوم / 200 يوم
KWD 2.36
8.90% above

Quick Summary

النقاط الرئيسية

Revenue grew 0.28% annually over 5 years — modest growth
Negative free cash flow of -840,000.0
Revenue growth is decelerating — 1Y growth trails 5Y average by 18.33%
Capital efficient — spends only 0.39% of revenue on capex

النمو

Revenue Growth (5Y)
0.28%
أقل من متوسط القطاع (1.82%)
Revenue (1Y)-18.05%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-130.81%
أقل من متوسط القطاع (-53.41%)
ROIC-11.88%
Net Margin-39.02%
Op. Margin-13.85%

الأمان

Debt / Equity
0.70
أعلى من متوسط القطاع (0.31)
Current Ratio1.16
Interest Coverage-3.21

التقييم

PE (TTM)
-1.13
أعلى من متوسط القطاع (-1.48)
P/B Ratio1.94
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1364 نظير)
المقياس السهم وسيط القطاع
P/E -1.1 -1.5
P/B 1.9 1.6
ROE % -130.8 -53.4
Net Margin % -39.0 -41.5
Rev Growth 5Y % 0.3 1.8
D/E 0.7 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) -18.05% Revenue Growth (3Y) -21.38%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 0.28% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 62.64 M Net Income (TTM) -24.44 M
ROE -130.81% ROA -19.79%
Gross Margin 66.84% Operating Margin -13.85%
Net Margin -39.02% Free Cash Flow (TTM) -840,000.0
ROIC -11.88% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.70 Current Ratio 1.16
Interest Coverage -3.21 Asset Turnover 0.51
Working Capital 10.68 M Tangible Book Value -29.38 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1.13 Forward P/E N/A
P/B Ratio 1.94 P/S Ratio 0.44
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -3.05%
Market Cap 27.58 M Enterprise Value 7.56 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share 5.84
FCF / Share -0.08 OCF / Share -0.06
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0.39% FCF Conversion 3.44%
SBC-Adj. FCF -1.55 M Growth Momentum -18.33

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 66.38 M 81.00 M 107.40 M 96.67 M 65.63 M
Net Income -13.56 M -15.84 M -17.05 M -110.17 M -58.29 M
EPS (Diluted) — — -5.11 -3.75 —
Gross Profit 45.83 M 54.59 M 66.63 M 52.28 M 29.20 M
Operating Income -7.83 M -5.25 M -17.07 M -111.56 M -58.87 M
EBITDA — — — — —
R&D Expenses 1.33 M 2.79 M 4.10 M 14.44 M 5.62 M
SG&A Expenses — — — — —
D&A — 8.27 M 8.82 M 10.25 M 9.20 M
Interest Expense 3.70 M 4.79 M — 900,000.0 —
Income Tax 437,000.0 1.77 M 0.0 -110,000.0 259,000.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 124.18 M 118.10 M 136.46 M 137.62 M 265.67 M
Total Liabilities — — 97.11 M 91.53 M 128.10 M
Shareholders' Equity 18.97 M 27.72 M 39.36 M 46.09 M 137.57 M
Total Debt 10.90 M 13.27 M 16.56 M 15.00 M —
Cash & Equivalents 30.95 M 20.01 M 22.99 M 19.36 M 49.65 M
Current Assets 79.18 M — 72.83 M 59.93 M 105.23 M
Current Liabilities 63.06 M 62.23 M 69.02 M 64.44 M 109.44 M